Skip to content
FABPulous logo — Developing ultra-rapid diagnostics for primary care and emer...

FABPulous

Developing ultra-rapid diagnostics for primary care and emergency medicine.

Founded 2000 Venture round Total: $3.43M Biotechnology, Care Economy +1

General Information

Company Name FABPulous
Founded Year 2000
Industries Biotechnology, Care Economy, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with FABPulous. To contact FABPulous, visit fabpulous.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FABPulous compare?

A PDF of FABPulous and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FABPulous soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FABPulous

FABPulous is a pioneering healthcare company based in The Netherlands, established in 2008 as a spinoff from Maastricht University. The company secured its initial equity financing in December 2009 with key investors including Thuja Capital, Health Innovations, Limburg Ventures, and NV Industriebank LIOF. The firm's innovative technology allows for rapid diluted plasma preparation from a single drop of blood, offering significant advantages for point-of-care and home testing applications. Their cutting-edge disposable plasma preparation device is designed to seamlessly integrate with various IVD detection platforms, including lateral flow devices. FABPulous' first product currently in development is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), aimed at facilitating early diagnosis of acute myocardial infarction.

Founded in 2000, FABPulous operates in the Biotechnology and Health Care industries, with a notable Venture Round investment received on October 17, 2017 from the Health Innovation Fund. The company's focus on developing ultra-rapid diagnostics for primary care and emergency medicine showcases its commitment to advancing healthcare accessibility and effectiveness.

Business keywords: Medical Diagnostics, Point-of-Care Testing, Emergency Medicine, Primary Care, Rapid Diagnostics, Cardiac Biomarkers, Medical Technology, Startup, Investment, Biotech, Netherlands, Maastricht University, Equity Financing, Health Innovations

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Health Innovation Fund
17 Oct 2017
Grant €1.63M 1
EASME - EU Executive Agency for SMEs
01 Apr 2015
Series B €1.80M 3
Thuja Capital, Limburg Startup +1
04 Feb 2015
Series A Undisclosed 5
Thuja Capital, Limburg Startup +3
11 Jan 2010

FABPulous Alternatives & Competitors

View All Alternatives
FABPulous vs

Our Tests. Your Total Solution.

Post-IPO Debt
74 employees
Biotechnology, Health Care
FABPulous vs
Haemokinesis
Haemokinesis Australia

When every second counts.

34 employees
Biotechnology, Health Care
FABPulous vs

Smart testing platform for rapid and accurate testing of diseases and various health condition in hu...

2-10 employees
Biotechnology, Health Care

FAQ About FABPulous

Developing ultra-rapid diagnostics for primary care and emergency medicine.
FABPulous was founded in 2000.
FABPulous operates in Biotechnology, Care Economy and Health Care. Its work centres on Medical Diagnostics, Point-of-Care Testing, Emergency Medicine and Primary Care.
FABPulous has completed 4 funding rounds, raising a total of $3.43M. The latest funding stage is Venture round.
Top alternatives and competitors to FABPulous include Response Biomedical Corp., Haemokinesis, Droplite, Biosense Technologies , Calmark Sweden AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FABPulous and Response Biomedical Corp. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FABPulous, https://bouncewatch.com/company/fabpulous, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout